Skip to main content
Premium Trial:

Request an Annual Quote

European Investment Group Permira to Acquire for $1.6B

Premium and Permira this week announced a merger agreement under which Permira Advisors LLP, a company held by Permira and other investors, will acquire Provo, Utah-based for $32 per share in cash, a transaction valued at $1.6 billion.

The companies noted in a statement that the deal is subject to the approval of shareholders and customary closing conditions and that they expect it to close in early 2013.

Headquartered in London, Permira has offices around the world and advises funds with a total committed capital of $26 billion. CEO Tim Sullivan said that the agreement with Permira will allow it to "keep investing in our technology and product experience" and to "make family history easy and accessible for more and more families around the world."

In addition to offering its 2-million-plus subscribers access to digitized and indexed records, in May entered the genetic genealogy market, launching AncestryDNA, an autosomal DNA testing service (BAN 5/29/2012). AncestryDNA relies on Illumina HumanOmniExpress BeadChips to generate data that is used to inform clients about their relationships to other subscribers and deep ancestry. The company recently said it plans to make the raw data from the service downloadable for interested users (see related story, this issue).

Should the deal close as expected,'s focus will "continue to be on investing in content, technology, and its user experience, expanding its product offerings in areas like DNA, and building the brand and the family history category, all on a global basis," the companies said. said it will file additional details regarding the transaction shortly with the US Securities and Exchange Commission, and in proxy materials to be provided to the company's stockholders in connection with a special meeting to vote on the merger.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.